Eve-Lyne Marchand

Dr. Eve-Lyne Marchand serves as an Assistant Clinical Professor in the Department of Radiology, Radiation Oncology and Nuclear Medicine at the University of Montreal, providing specialized radiation oncology care at Maisonneuve-Rosemont Hospital since 2013. Her clinical expertise focuses on gynecological and hematological malignancies, integrating advanced radiotherapy techniques with multidisciplinary patient management while maintaining strong longitudinal therapeutic relationships through comprehensive treatment monitoring.

Her educational background includes:

• Bachelor of Science in Biochemistry from University of Montreal
• PhD in Pharmacology (2003) from University of Montreal, researching cardiovascular remodeling with CIHR scholarship
• Doctor of Medicine (2007) from University of Montreal
• Radiation Oncology Residency (2012) from University of Toronto/Princess Margaret Hospital
• Subspecialty Fellowships in gynecological cancer treatment and quality indicators at University of Toronto/Queen's University

Dr. Marchand's research centers on technological innovation in radiation delivery systems and precision oncology. Key focus areas include:

• Interstitial brachytherapy implementation for gynecological/breast cancers
• Radiotherapy bridging protocols for CAR T-cell therapy in lymphoma
• Transition from cobalt to linear accelerator treatments for bone marrow transplant patients
• Biomarker development using circulating HPV DNA for cervical cancer recurrence prediction

Her 2024 Journal of Clinical Oncology publication exemplifies her translational approach, demonstrating how viral DNA detection in blood can stratify recurrence risk after cervical cancer treatment. This work reflects her broader research trajectory toward personalized, biomarker-driven radiotherapy protocols that directly enhance clinical decision-making.

As Chair of the Departmental Research Grant Allocation Committee and Summer Student Grant Program, she directs funding distribution for resident and undergraduate research initiatives. She actively mentors medical students through the Introduction to Clinical Method course and supervises radiation oncology residents, emphasizing evidence-based practice and technological innovation in clinical training.

Dr. Marchand collaborates extensively within multidisciplinary teams including radiation oncologists (Drs. Audrey Roux, Israël Fortin, Maryse Bernard), hematologist-oncologist Dr. Isabelle Fleury, and national/international research groups. Her institutional innovations—such as interstitial brachytherapy implementation and novel radiotherapy protocols for CAR T-cell therapy—demonstrate systematic integration of research findings into clinical workflows at Maisonneuve-Rosemont Hospital.